AMSTERDAM SUPPORT DIAGNOSTICS has a total of 23 patent applications. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are EDBERG STEPHEN C, GFE Blut mbH and KORFHAGE CHRISTIAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 5 | |
#4 | Canada | 2 | |
#5 | Netherlands | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Microorganisms | |
#3 | Analysing materials | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Goudsmit Jaap | 12 |
#2 | Van Gemen Bob | 8 |
#3 | Sol Cornelis Johannes Andreas | 6 |
#4 | Beld Marcellinus Gualbertus Hu | 6 |
#5 | Boom Willem Rene | 6 |
#6 | Van Der Kuyl Antoinette Cornel | 6 |
#7 | Loukachov Vladimir V | 3 |
#8 | Mang Rui | 3 |
#9 | Dekker John | 3 |
#10 | Timmermans Eveline Catherina A | 3 |
Publication | Filing date | Title |
---|---|---|
EP1225233A2 | Means and methods for treatment evaluation | |
CA2369183A1 | Means and methods for treatment evaluation | |
EP1130119A1 | Reducing background in hybridisation reactions | |
WO0151661A2 | A universal nucleic acid amplification system for nucleic acids in a sample | |
EP1211323A1 | Tests based on nucleic acids of endosymbiont cellular organelles | |
EP1174518A1 | Collection of binding molecules | |
EP1160332A1 | Methods for detecting enzymatic activity or detecting resistance to enzyme inhibitors | |
EP1106703A1 | Testing xenografts and sources thereof for retrovirus | |
AU1676597A | Separation of single stranded and double stranded nucleic acid materials | |
NL1003839C2 | Diagnostic test. | |
NL1002781C1 | Isolation and / or amplification of hepatitis C virus (HCV) nucleic acids from samples suspected of containing HCV. |